Living with Silent Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease characterized by the accumulation of lipids in liver cells not associated with the consumption of alcohol. It causes cellular dysfunction and, in some people, leads to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. Estimates show that 357 million people will have NASH globally by 2030.Because NASH symptoms are not obvious, it is often underdiagnosed and underreported. Federally Qualified Health Care (FQHC) centers and their staff of community-based healthcare providers play a critical role in meeting the primary healthcare needs of underserved populations and ensuring access to care. Part of the epidemiology of chronic diseases that are managed in the FQHC system also includes diabetes, hypertension, and obesity.Dr. Robert Gish, Medical Director, Hepatitis B Foundation, WILL discuss the burden of these diseases and the importance of early detection for liver diseases like NAFLD and NASH in a community health center setting. To learn more about liver diseases, check out this podcast from NASHNET, a global network of thought leaders dedicated to innovating NASH care delivery.